[go: up one dir, main page]

EP1242443A4 - Neue nukleinsäuren und polypeptide - Google Patents

Neue nukleinsäuren und polypeptide

Info

Publication number
EP1242443A4
EP1242443A4 EP00990231A EP00990231A EP1242443A4 EP 1242443 A4 EP1242443 A4 EP 1242443A4 EP 00990231 A EP00990231 A EP 00990231A EP 00990231 A EP00990231 A EP 00990231A EP 1242443 A4 EP1242443 A4 EP 1242443A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
new nucleic
new
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00990231A
Other languages
English (en)
French (fr)
Other versions
EP1242443A1 (de
Inventor
Y Tom Tang
Chenghua Liu
Vinod Asundi
Rui-Hong Chen
Yunqing Ma
Xiaohong B Qian
Feiyan Ren
Dunrui Wang
Jian-Rui Wang
Zhiwei Wang
Tom Wehrman
Chongjun Xu
Aidong J Xue
Yonghong Yang
Jie Zhang
Qing A Zhao
Ping Zhou
Ryle Goodrich
Radoje T Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/620,312 external-priority patent/US6569662B1/en
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1242443A1 publication Critical patent/EP1242443A1/de
Publication of EP1242443A4 publication Critical patent/EP1242443A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP00990231A 1999-12-23 2000-12-26 Neue nukleinsäuren und polypeptide Withdrawn EP1242443A4 (de)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US662191 1991-02-28
US47127599A 1999-12-23 1999-12-23
US471275 1999-12-23
US48872500A 2000-01-21 2000-01-21
US488725 2000-01-21
US55231700A 2000-04-25 2000-04-25
US552317 2000-04-25
US59804200A 2000-06-20 2000-06-20
US598042 2000-06-20
US09/620,312 US6569662B1 (en) 2000-01-21 2000-07-19 Nucleic acids and polypeptides
US620312 2000-07-19
US653450 2000-08-03
US65345000A 2000-08-31 2000-08-31
US66219100A 2000-09-14 2000-09-14
US69303600A 2000-10-19 2000-10-19
US693036 2000-10-19
US72734400A 2000-11-29 2000-11-29
WOPCT/US72/07344 2000-11-29
PCT/US2000/034263 WO2001053312A1 (en) 1999-12-23 2000-12-26 Novel nucleic acids and polypeptides

Publications (2)

Publication Number Publication Date
EP1242443A1 EP1242443A1 (de) 2002-09-25
EP1242443A4 true EP1242443A4 (de) 2005-06-22

Family

ID=27578844

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00990231A Withdrawn EP1242443A4 (de) 1999-12-23 2000-12-26 Neue nukleinsäuren und polypeptide

Country Status (3)

Country Link
EP (1) EP1242443A4 (de)
CA (1) CA2402563A1 (de)
WO (1) WO2001053312A1 (de)

Families Citing this family (200)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2577799A (en) 1998-02-09 1999-08-23 Human Genome Sciences, Inc. 45 human secreted proteins
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US6369197B1 (en) 1998-11-20 2002-04-09 Millennium Pharmaceuticals, Inc. Potassium channel interactors and uses therefor
US7078481B1 (en) 1998-11-20 2006-07-18 Wyeth Potassium channel interactors and uses therefor
US7465785B2 (en) 1999-03-08 2008-12-16 Genentech, Inc. Polypeptide encoded by a nucleic acid over-expressed in melanoma
DK1626058T3 (da) * 1999-03-08 2008-02-25 Genentech Inc Sammensætninger og fremgangsmåder til diagnosticering af tumor
US8410248B2 (en) 1999-03-12 2013-04-02 Human Genome Sciences Inc. HWBAO62 polypeptides
US6242419B1 (en) * 1999-03-25 2001-06-05 Genesis Research & Development Corporation Ltd. Compositions isolated from stromal cells and methods for their use
US7083791B2 (en) 1999-03-25 2006-08-01 Genesis Research & Development Corporation Limited Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2000073468A1 (en) 1999-05-28 2000-12-07 Immunex Corporation Novel murine and human kinases
EP1623993A3 (de) * 1999-09-01 2006-06-07 Genetech, Inc. Ausgeschiedene und Transmembranpolypeptide und dafür kodierende Nukleinsäure
CA2492049A1 (en) * 1999-12-01 2001-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7423127B2 (en) * 1999-12-09 2008-09-09 Genentech, Inc. Antibodies to a polypeptide encoded by a nucleic acid overexpressed in melanoma
US20090176722A9 (en) 2000-01-28 2009-07-09 Shiv Srivastava Androgen-regulated PMEPA1 gene and polypeptides
WO2001059080A1 (en) * 2000-02-11 2001-08-16 Millennium Pharmaceuticals, Inc. 18477, a human protein kinase and uses therefor
US6479270B1 (en) 2000-02-14 2002-11-12 Pe Corporation (Ny) Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
NZ520802A (en) * 2000-02-17 2005-02-25 Aventis Pharma S Compositions useful for regulating parkin gene activity
JP2003525610A (ja) * 2000-03-02 2003-09-02 キュラゲン コーポレイション 熱応答に関連する遺伝子ｇ１２ｌ
US20020111307A1 (en) * 2000-06-23 2002-08-15 Glucksmann Maria Alexandra 46508, a novel human peptidyl-tRNA hydrolase family member and uses thereof
US20040214758A1 (en) 2000-03-24 2004-10-28 Meyers Rachel E. Novel human hydrolase family members and uses thereof
IL151987A0 (en) * 2000-03-31 2003-04-10 Aventis Pharma Inc Nuclear factor kb inducing factor
GB0018307D0 (en) 2000-07-26 2000-09-13 Aventis Pharm Prod Inc Polypeptides
AU2001253123A1 (en) * 2000-04-12 2001-10-30 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Identification of a renal nadph oxidase
US7183075B2 (en) * 2000-04-14 2007-02-27 Vanderbilt University Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
WO2001081559A2 (en) * 2000-04-26 2001-11-01 Millennium Pharmaceuticals, Inc. 26335, a novel human serine/threonine dehydratase and uses thereof
US20030083244A1 (en) * 2000-04-26 2003-05-01 Vernet Corine A.M. Novel proteins and nucleic acids encoding same
US20020177148A1 (en) * 2001-01-22 2002-11-28 Millennium Pharmaceuticals, Inc. FBH58295FL, a novel human amino acid transporter and uses thereof
US6461846B2 (en) 2000-05-30 2002-10-08 Pe Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
DE10027170A1 (de) * 2000-05-31 2001-12-13 Schering Ag Humanes PEM als Target für die Fertilitätskontrolle
WO2001094413A2 (en) 2000-06-06 2001-12-13 Bristol-Myers Squibb Company B7-related nucleic acids and polypeptides and their uses for immunomodulation
WO2001096375A2 (en) * 2000-06-16 2001-12-20 Millennium Pharmaceuticals, Inc. 33358, a novel human ankyrin family member and uses thereof
FR2810673B1 (fr) * 2000-06-26 2004-10-08 Univ Toulouse Dynamine mitochondriale humaine msp1 et son utilisation en therapeutique
US6900303B2 (en) 2000-06-30 2005-05-31 Millennium Pharmaceuticals, Inc. 57658, a novel human uridine kinase and uses thereof
US20020137181A1 (en) * 2000-07-18 2002-09-26 Rachel Meyers 14087, a novel serine protease molecule and uses therefor
WO2002008282A2 (en) * 2000-07-26 2002-01-31 Stanford University Bstp-ras/rerg protein and related reagents and methods of use thereof
JP2005503101A (ja) * 2000-08-01 2005-02-03 オレゴン ヘルス アンド サイエンス ユニバーシティ 哺乳動物のｄｎａを結合する膜結合タンパク質をコードする遺伝子およびその使用
EP1307557A2 (de) 2000-08-02 2003-05-07 The Johns Hopkins University Expressionsmuster von endothelzellen
JP2004510415A (ja) * 2000-08-03 2004-04-08 インサイト・ゲノミックス・インコーポレイテッド インテグリン
CN1310942C (zh) * 2000-08-04 2007-04-18 路德维希癌症研究院 校正基因
PT1313850E (pt) * 2000-08-28 2008-11-18 Agensys Inc Ácido nucleico e proteína correspondente denominados 85p1b3 úteis no tratamento e na detecção de cancro
AU2001282109A1 (en) * 2000-08-31 2002-03-13 Bayer Aktiengesellschaft Regulation of human l-asparaginase-like enzyme
WO2002018424A2 (en) * 2000-09-01 2002-03-07 Hyseq, Inc. Nucleic acids and polypeptides
AU2001287448A1 (en) * 2000-09-01 2002-03-13 The Governing Council Of The University Of Toronto Proteins related to schizophrenia and uses thereof
WO2002024911A2 (en) * 2000-09-19 2002-03-28 Millennium Pharmaceuticals, Inc. 63760, a novel human transporter and uses thereof
EA200300420A1 (ru) * 2000-09-27 2004-04-29 Милленниум Фамэсьютикэлс, Инк. Выделенная молекула нуклеиновой кислоты, выделенный полипептид и способ его получения, способ обнаружения их присутствия в образце (варианты), клетка-хозяин (варианты), антитело, набор (варианты), способ модулирования активности полипептида, способ идентификации (варианты) и применение соединения, способ выявления субъекта (варианты) и способ лечения субъекта с нарушением, связанным с калиевыми каналами (варианты)
AU2001293830A1 (en) * 2000-09-27 2002-04-08 Bayer Aktiengesellschaft Regulation of human aminotransferase-like enzyme
WO2002026957A2 (en) * 2000-09-28 2002-04-04 Bayer Aktiengesellschaft Regulation of a human serine protease
GB0024086D0 (en) * 2000-10-02 2000-11-15 Inpharmatica Ltd Proteinase
US6911336B2 (en) * 2000-10-18 2005-06-28 Immunex Corporation GNK interacting amino acid decarboxylase and methods of use thereof
AUPR107800A0 (en) * 2000-10-27 2000-11-23 University Of Sydney, The Peptide and nucleic acid molecule ii
AUPR121300A0 (en) * 2000-11-03 2000-11-30 Monash University Cell division autoantigen (CDA) polypeptides, gene sequences and uses thereof
JP2004528822A (ja) * 2000-11-07 2004-09-24 ボード・オブ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム 筋特異的筋節カルシニューリン結合タンパク質（カルサルシン）に関する方法および組成物
CA2429376A1 (en) 2000-11-16 2002-10-17 Emory University Mitogenic oxygenase regulators
AU2002224853A1 (en) * 2000-11-17 2002-05-27 Bayer Aktiengesellschaft A human trna-specific adenosine deaminase
EP1209229A1 (de) * 2000-11-21 2002-05-29 Klaus-Peter Department of Psychiatry and Psychotherapy University of Würzburg Lesch Gen, das in der Schizophrenie beteiligt ist
EP1395657B1 (de) 2000-12-05 2007-04-18 Wisconsin Alumni Research Foundation Rezeptor für ein toxin aus bacillus anthracis
US20040072997A1 (en) * 2000-12-20 2004-04-15 Alsobrook John P. Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA2406028A1 (en) * 2000-12-21 2002-06-27 Genox Research, Inc. Method for testing for allergic disease
WO2002062948A2 (en) * 2000-12-22 2002-08-15 Millennium Pharmaceuticals, Inc. 25828, a novel human aminopeptidase and uses therefor
AU2002238483A1 (en) * 2001-01-03 2002-07-16 Bayer Aktiengesellschaft Regulation of human ornithine decarboxylase
AUPR278301A0 (en) 2001-01-31 2001-02-22 Bionomics Limited A novel gene
WO2002057444A1 (fr) * 2001-01-22 2002-07-25 Shinae Kondoh Genes associes a l'apoptose humaine et proteines produites associees a l'apoptose humaine
US6686176B2 (en) * 2001-01-23 2004-02-03 Applera Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
US7601825B2 (en) 2001-03-05 2009-10-13 Agensys, Inc. Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
EP1358326A2 (de) * 2001-02-09 2003-11-05 Incyte Genomics, Inc. Mit zellwachstum, differenzierung und zelltod assoziierte proteine
AU2002247716A1 (en) * 2001-02-14 2002-08-28 Axaron Bioscience Ag Proteins 7b6 and 11b4 and dna sequences encoding the same
WO2002064786A1 (fr) * 2001-02-15 2002-08-22 Mochida Pharmaceutical Co., Ltd. Nouveau gene tcif
US6461843B1 (en) 2001-02-16 2002-10-08 Applera Corporation Isolated nucleic acid molecules encoding human enzyme proteins, and uses thereof
JP2004532619A (ja) 2001-02-16 2004-10-28 ブリストル−マイヤーズ　スクイブ　カンパニー 細胞内シグナル伝達カスケードに関与する新規なヒト遺伝子ｒｅｔ１６の同定およびクローニング
GB0104440D0 (en) * 2001-02-22 2001-04-11 Oxford Biomedica Ltd Novel genes
US6924358B2 (en) * 2001-03-05 2005-08-02 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
JP2005508606A (ja) * 2001-03-16 2005-04-07 インサイト・ゲノミックス・インコーポレイテッド 核酸関連タンパク質
US8981061B2 (en) 2001-03-20 2015-03-17 Novo Nordisk A/S Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
US8231878B2 (en) 2001-03-20 2012-07-31 Cosmo Research & Development S.P.A. Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
WO2002077219A1 (en) * 2001-03-26 2002-10-03 Lexicon Genetics Incorporated Novel human asparaginases and polynucleotides encoding the same
US6867019B2 (en) * 2001-03-27 2005-03-15 Applera Corporation Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
CA2442134A1 (en) 2001-03-29 2002-10-10 Celltech R & D, Inc. Compositions and methods for diagnosing or treating psoriasis
US20030044813A1 (en) * 2001-03-30 2003-03-06 Old Lloyd J. Cancer-testis antigens
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
FR2823221B1 (fr) 2001-04-06 2004-04-02 Univ Pasteur Sequences associees a la degenerescence retinienne et applications
AU2002308139A1 (en) * 2001-04-12 2002-10-28 Bayer Aktiengesellschaft Regulation of human methionine aminopeptidase-like protein
EP1258495A1 (de) * 2001-05-09 2002-11-20 Millennium Pharmaceuticals, Inc. 98359, Natriumkanal-beta-4 Untereinheit, und deren Verwendungen
US7335755B2 (en) * 2001-05-30 2008-02-26 Hisamitsu Pharmaceutical Co., Inc. Nucleic acids isolated in neuroblastoma
EP1572877A3 (de) * 2001-07-06 2005-10-05 Incyte Genomics, Inc. Wirkstoffmetabolisierende enzyme
AU2002325196A1 (en) * 2001-07-09 2003-01-29 Kobenhavns Universitet Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer
IL159872A0 (en) * 2001-07-26 2004-06-20 Genset Sa Gmg-2 polypeptides and their use
US7413870B2 (en) * 2001-08-01 2008-08-19 Rigel Pharmaceuticals, Incorporated SAK: modulation of cellular proliferation for treatment of cancer
FR2828209A1 (fr) * 2001-08-01 2003-02-07 Cytomics Systems Acides nucleiques codant de nouvelles proteines a domaine hect, leurs utilisations en diagnostics et en therapie
US20030104385A1 (en) * 2001-08-02 2003-06-05 Evans Glen A. Nucleic acids and encoded polypeptides associated with bipolar disorder
WO2003018805A1 (fr) * 2001-08-23 2003-03-06 Japan Science And Technology Agency Regulateurs de la proliferation de cellules souches hematopoietiques et polynucleotides codant ces regulateurs
JP2003135063A (ja) * 2001-08-24 2003-05-13 Chiba Prefecture 新規な遺伝子ｎｅｄｌ−１
JP4625633B2 (ja) * 2001-08-27 2011-02-02 独立行政法人科学技術振興機構 細胞移動調節及び細胞死調節機能を有するタンパク質
US20030073118A1 (en) * 2001-08-31 2003-04-17 Millennium Pharmaceuticals, Inc. MID 9002, a human sulfatase family member and uses therefor
AU2008201996B2 (en) * 2001-09-18 2011-02-10 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP2174953A1 (de) * 2001-09-18 2010-04-14 Genentech, Inc. Zusammensetzungen und Verfahren zur Behandlung und Diagnose von Tumoren
JP4232423B2 (ja) * 2001-09-28 2009-03-04 第一三共株式会社 新規ユビキチン特異プロテアーゼ
US20030134306A1 (en) * 2001-10-03 2003-07-17 Baum Peter R. Human and murine cytokine polypeptides
WO2003038093A2 (en) * 2001-10-30 2003-05-08 Bayer Healthcare Ag Regulation of human l-serine dehydratase
JP2005507669A (ja) * 2001-10-31 2005-03-24 ミレニアム・ファーマシューティカルズ・インコーポレイテッド ２５９４３を用いる細胞増殖障害の処置および診断のための方法および組成物
US20030153525A1 (en) * 2001-12-19 2003-08-14 Millennium Pharmaceuticals, Inc. Methods and compositions in treating pain and painful disorders using 1465, 1587, 2146, 2207, 32838, 336 and 52908
US7166713B2 (en) * 2001-12-11 2007-01-23 Texas Techn University Variant cleavage stimulation factor and its encoding nucleic acid
WO2003057867A2 (en) * 2002-01-10 2003-07-17 Bayer Healthcare Ag Regulation of human fatty acid coa ligase-like amp-binding enzyme
WO2003060129A1 (en) * 2002-01-16 2003-07-24 Bayer Healthcare Ag Regulation of human fatty acid coa ligase-like amp-binding enzyme
WO2003060110A2 (en) * 2002-01-16 2003-07-24 Bayer Healthcare Ag Regulation of human fatty acid coa ligase-like amp-binding enzyme
WO2003062379A2 (en) * 2002-01-17 2003-07-31 Incyte Genomics, Inc. Molecules for disease detection and treatment
AU2003227179A1 (en) * 2002-02-08 2003-09-09 Amersham Biosciences K.K. Fused protein having glucuronyl transferase activity
JP2003250550A (ja) * 2002-02-25 2003-09-09 Nissui Pharm Co Ltd 脂肪細胞分化関連遺伝子およびタンパク質
GB0206684D0 (en) * 2002-03-21 2002-05-01 Babraham Inst Novel proteins
US7193069B2 (en) * 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
WO2003080825A2 (en) * 2002-03-27 2003-10-02 Bayer Healthcare Ag Further bmp-2 inducible kinases and the uses thereof
WO2003083096A2 (en) * 2002-03-28 2003-10-09 Qlt Inc. Cancer associated protein kinases and their uses
WO2003083110A1 (fr) * 2002-03-29 2003-10-09 National Institute Of Advanced Industrial Science And Technology Nouvelles galactose transferases et leurs peptides, et acide nucleique codant pour lesdites transferases
US20050202431A1 (en) * 2002-04-01 2005-09-15 National Institute Of Advanced Industrial Science Application of kiaa0172 gene to treatment and diagnosis of diseases and drug discovery
EP2011886A3 (de) * 2002-04-16 2009-02-11 Genentech, Inc. Zusammensetzungen und Verfahren zur Behandlung und Diagnose von Tumoren
WO2003093826A2 (en) * 2002-04-29 2003-11-13 Clinigenetics Assays for identifying cholesterol - lowering molecules
US7009038B2 (en) 2002-05-02 2006-03-07 Univ. Of Medicine & Dentistry Of N.J. pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof
EP2269628A3 (de) 2002-05-29 2011-04-20 DeveloGen Aktiengesellschaft Pankreas spezifische proteine
ATE380869T1 (de) 2002-06-07 2007-12-15 Trillium Therapeutics Inc Fcyriia-transgenes tiermodell für autoimmunkrankheit
US20050221328A1 (en) * 2002-06-13 2005-10-06 Wyeth Inhibitors of inflammatory gene activity and cholesterol biosynthesis
GB0214543D0 (en) * 2002-06-24 2002-08-07 Ares Trading Sa Proteins
AU2003244191A1 (en) * 2002-06-26 2004-01-19 Takeda Pharmaceutical Company Preventives/remedies for cancer
EP1541677A4 (de) * 2002-07-10 2007-06-27 Takeda Pharmaceutical Neue proteine und verwendung davon
JP2004097199A (ja) * 2002-07-15 2004-04-02 Keio Gijuku 腫瘍抗原のスクリーニング方法
WO2004009622A2 (en) * 2002-07-19 2004-01-29 Cellzome Ag Protein complexes of cellular networks underlying the development of cancer and other diseases
WO2004009783A2 (en) 2002-07-24 2004-01-29 New York University Truncated rgr in t cell malignancy
WO2004013320A1 (en) * 2002-07-30 2004-02-12 Bayer Healthcare Ag Regulation of human methyltransferase
GB0217631D0 (en) * 2002-07-30 2002-09-11 Inpharmatica Ltd Proteins
WO2004020620A1 (en) * 2002-08-13 2004-03-11 Bayer Healthcare Ag Regulation of human esterase
AU2003260460A1 (en) * 2002-08-28 2004-03-19 Evotec Neurosciences Gmbh Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases
EP1396544A1 (de) * 2002-09-06 2004-03-10 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Nukleinsäuren, die für menschliche Thyroiddehydrogenasen kodieren
AU2003263150A1 (en) * 2002-09-12 2004-04-30 Pharmexa A/S Immunization against autologous ghrelin
AU2003296554A1 (en) * 2002-09-13 2004-05-04 Ingenium Pharmaceuticals Ag Animal with modification of cytoplasmic dynein heavy chain 1 gene
AU2003266605A1 (en) * 2002-09-27 2004-04-19 Takeda Pharmaceutical Company Limited Preventives/remedies for neurodegenerative disease
US7662917B2 (en) 2002-09-30 2010-02-16 Ludwig Institute For Cancer Research Human sarcoma-associated antigens
US7560537B2 (en) * 2002-09-30 2009-07-14 Ludwig Institute For Cancer Research Human sarcoma-associated antigens
WO2004039974A1 (ja) * 2002-10-30 2004-05-13 Takeda Pharmaceutical Company Limited 新規タンパク質およびそのｄｎａ
WO2004039980A1 (en) * 2002-10-30 2004-05-13 Cancer Research Technology Limited Agents modulating mal activity
US7060797B2 (en) * 2002-11-21 2006-06-13 Wyeth Composition and method for treating lupus nephritis
GB0228337D0 (en) * 2002-12-05 2003-01-08 Yorkshire Cancer Res Campaign Replication protein
DE60336015D1 (de) * 2002-12-24 2011-03-24 Univ Beijing Menschliche Gene in Verbindung mit Krebs, davon kodierte Produkte und Anwendungen davon
US20050015821A1 (en) * 2003-02-21 2005-01-20 Phenomix Corporation Sensin polypeptides, encoding nucleic acids, mutations, and methods of their identification and use
WO2004081039A1 (ja) * 2003-03-10 2004-09-23 Takeda Pharmaceutical Company Limited 新規タンパク質およびそのｄｎａ
AU2003901511A0 (en) * 2003-03-28 2003-04-17 Bionomics Limited Nucleic acid molecules associated with angiogenesis II
EP1464651A1 (de) * 2003-04-03 2004-10-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Dystrophin-verwandte Protein (Drop1) als Marker für Krebs
US7829682B1 (en) * 2003-04-30 2010-11-09 Incyte Corporation Human β-adrenergic receptor kinase nucleic acid molecule
CN1244595C (zh) * 2003-05-14 2006-03-08 中国科学院上海生命科学研究院 一种肿瘤抑制蛋白及其应用
JPWO2005017155A1 (ja) * 2003-06-18 2006-10-12 中外製薬株式会社 フコーストランスポーター
FR2843753A1 (fr) * 2003-06-20 2004-02-27 Gene Signal Genes impliques dans la regulation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
JPWO2004113532A1 (ja) * 2003-06-21 2006-08-03 繁樹 東山 細胞増殖抑制剤スクリーニング用タンパク質及び細胞増殖抑制剤のスクリーニング方法並びに細胞増殖抑制剤
WO2005003336A2 (en) * 2003-07-07 2005-01-13 Universiteit Utrecht Holding B.V. Newly identified cholinephosphotransferases and ethanolaminephosphotransferases
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
EP1699478A2 (de) * 2003-09-23 2006-09-13 Meyer Pharmaceuticals, LLC Behandlung von entzündung mit einem biologischen mittel, das zur freisetzung von zytokin-rezeptoren aus zellen führt
JP2005168338A (ja) * 2003-12-09 2005-06-30 Japan Science & Technology Agency 新規タンパク質カルフォグリン、これをコードする遺伝子、薬剤、及び標的物質
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
WO2005090574A1 (ja) * 2004-03-19 2005-09-29 Genomidea Inc. 血管内皮増殖抑制遺伝子
GB0407587D0 (en) * 2004-04-02 2004-05-05 Univ Nottingham Trent Cancer associated antigens
CN101061239B (zh) * 2004-09-24 2011-08-17 肿瘤疗法科学股份有限公司 通过URLC8的tRNA-二氢尿苷合酶活性诊断非小细胞肺癌的方法
MX2007005764A (es) * 2004-11-22 2007-07-20 Wyeth Corp Metodos y sistemas para el pronostico y tratamiento de tumores solidos.
GB0426146D0 (en) 2004-11-29 2004-12-29 Bioxell Spa Therapeutic peptides and method
DE102004059781A1 (de) * 2004-12-10 2006-06-22 Sanofi-Aventis Deutschland Gmbh Verwendung der Serum-/Glucocorticoid regulierten Kinase
US7998695B2 (en) 2005-02-10 2011-08-16 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
EP1734118A1 (de) * 2005-06-15 2006-12-20 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Genom-weites RNAi-Screening zur Identifizierung von Genen die das JAK/STAT Pathway modulieren
WO2007028631A1 (en) * 2005-09-09 2007-03-15 H. Lundbeck A/S Genetic risk factor for neurodevelopmental disorders and their complications
US20070071755A1 (en) * 2005-09-27 2007-03-29 David Balasundaram Novel nucleolar GTPases and method for controlling proliferation of cells
WO2007088639A1 (ja) * 2006-02-01 2007-08-09 Hiroshima University Ｍ期キナーゼ基質タンパク質及びその使用
EP1815863A1 (de) * 2006-02-03 2007-08-08 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Verwendung von TLR3-Agonisten zur Behandlung von neurodegenerativen Krankheiten
US7884078B2 (en) 2006-02-10 2011-02-08 Massachusetts Institute Of Technology CPG15 compounds as insulin receptor and insulin-like growth factor receptor agonists
US8933209B2 (en) * 2006-04-26 2015-01-13 Abbvie Inc. Dep2 and its uses in major depressive disorder and other related disorders
US8318795B2 (en) 2007-03-01 2012-11-27 Cedars-Sinai Medical Center Antioxidant polymers containing [1,2]-dithiolane moieties and uses thereof
CA2685594A1 (en) * 2007-06-03 2008-12-11 Oncotx, Inc. Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
EP2027889A1 (de) * 2007-06-05 2009-02-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Neuer neuronaler Lebensfähigkeitsfaktor und seine Verwendung
US9028874B2 (en) 2008-01-03 2015-05-12 Cedars-Sinai Medical Center Antioxidant nanosphere comprising [1,2]-dithiolane moieties
EP2252707A2 (de) * 2008-03-14 2010-11-24 Exagen Diagnostics, Inc. Biomarker für chronisch-entzündliche darmerkrankung und reizdarmsyndrom
WO2009148698A1 (en) 2008-06-02 2009-12-10 Cedars-Sinai Medical Center Nanometer-sized prodrugs of nsaids
EP2370435B1 (de) 2008-11-24 2015-01-07 Cedars-Sinai Medical Center Antioxidative camptothecinderivate und antioxidative antineoplastische nanospheren davon
NZ594480A (en) 2009-02-20 2013-11-29 Ganymed Pharmaceuticals Ag Methods and compositions for diagnosis and treatment of cancer
ES2649389T3 (es) 2009-11-11 2018-01-11 Ganymed Pharmaceuticals Gmbh Anticuerpos específicos para claudina 6 (CLDN6)
EP2404936A1 (de) 2010-07-06 2012-01-11 Ganymed Pharmaceuticals AG Krebstherapie mittels CLDN6-zielgerichteter Antikörper im lebenden Organismus
HUE028603T2 (en) 2011-05-13 2016-12-28 Ganymed Pharmaceuticals Ag Antibodies for treatment of cancer expressing claudin 6
CA2836568C (en) * 2011-05-19 2020-07-21 Toray Industries, Inc. Immunity induction agent
WO2013104798A1 (en) * 2012-01-12 2013-07-18 Cemm - Center For Molecular Medicine Of The Austrian Academy Of Sciences Modulators of immune responses
EP2814842B1 (de) 2012-02-15 2018-08-22 Novo Nordisk A/S Antikörper die das peptidoglycan-erkennungs-protein erkennen
PL2814844T3 (pl) 2012-02-15 2017-12-29 Novo Nordisk A/S Przeciwciała wiążące i blokujące receptor aktywujący wykazujący ekspresję na komórkach szpikowych -1 (trem-1)
US9550830B2 (en) 2012-02-15 2017-01-24 Novo Nordisk A/S Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
US20130288980A1 (en) * 2012-04-02 2013-10-31 Buck Institute For Research On Aging Targeting senescent and cancer cells for selective killing by interference with foxo4
WO2015014376A1 (en) 2013-07-31 2015-02-05 Biontech Ag Diagnosis and therapy of cancer involving cancer stem cells
WO2016009086A1 (en) 2014-07-17 2016-01-21 Novo Nordisk A/S Site directed mutagenesis of trem-1 antibodies for decreasing viscosity
EP2977758A1 (de) * 2014-07-24 2016-01-27 Université De Nice Sophia Antipolis Verfahren und Kits zur Überwachung membranöser Nephropathie
AR102333A1 (es) * 2014-08-19 2017-02-22 Regeneron Pharma Selectividad eficiente de proteínas recombinadas
CN107257802B (zh) 2014-12-19 2021-11-23 豪夫迈·罗氏有限公司 转谷氨酰胺酶底物的鉴别及其用途
EP3233884B1 (de) 2014-12-19 2021-03-31 F. Hoffmann-La Roche AG Mikrobielle transglutaminasen, substrate dafür und verfahren zur verwendung davon
US11054425B2 (en) 2014-12-19 2021-07-06 Roche Sequencing Solutions, Inc. System and method for identification and characterization of transglutaminase species
GB201509134D0 (en) * 2015-05-28 2015-07-15 Electrophoretics Ltd Biomolecules involved in Alzheimer's disease
MX2018012758A (es) 2016-04-21 2019-01-31 Immatics Biotechnologies Gmbh Inmunoterapia contra el melanoma y otros tipos de cancer.
BR112018070873A2 (pt) 2016-04-21 2019-02-05 Immatics Biotechnologies Gmbh imunoterapia contra melanoma e outros cânceres
JOP20200240A1 (ar) 2018-04-02 2020-09-27 Bristol Myers Squibb Co أجسام مضادة ضد- trem-1 واستخداماتها
GB201807831D0 (en) * 2018-05-15 2018-06-27 Univ College Cardiff Consultants Ltd Cancer Vaccine
EP4110350A4 (de) * 2020-02-27 2024-04-03 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Cobra1/nelf-b als verstärker für die wirksamkeit einer therapie auf der basis von cd8+-t-zellen

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046281A2 (en) * 1998-03-10 1999-09-16 Genentech, Inc. Novel polypeptides and nucleic acids encoding the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175095A (en) * 1989-07-19 1992-12-29 Calgene, Inc. Ovary-tissue transcriptional factors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046281A2 (en) * 1998-03-10 1999-09-16 Genentech, Inc. Novel polypeptides and nucleic acids encoding the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JACOBS K A ET AL: "A genetic selection for isolating cDNAs encoding secreted proteins", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 198, no. 1-2, 1 October 1997 (1997-10-01), pages 289 - 296, XP004570106, ISSN: 0378-1119 *
See also references of WO0153312A1 *

Also Published As

Publication number Publication date
EP1242443A1 (de) 2002-09-25
WO2001053312A1 (en) 2001-07-26
WO2001053312A8 (en) 2002-06-20
CA2402563A1 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
EP1242443A4 (de) Neue nukleinsäuren und polypeptide
EP1325120A4 (de) Neue nukleinsäuren und polypeptide
EP1341804A4 (de) Neue nukleinsäuren und polypeptide
EP1504099A4 (de) Neue nukleinsäuren und polypeptide
EP1432800A4 (de) Neue nukleinsäuren und polypeptide
EP1556490A4 (de) Neue nukleinsäuren und polypeptide
EP1276751A4 (de) Neue nukleinsäuren und polypeptide
ATE554171T1 (de) Rezeptor-nukleinsäuren und -polypeptide
EP1368475A4 (de) Neue nukleinsäuren und polypeptide
AU2001234944A8 (en) Novel nucleic acids and polypeptides
AU2002368010A8 (en) Novel nucleic acids and secreted polypeptides
EP1483386A4 (de) Neue nukleinsäuren und abgesonderte polypeptide
EP1212344A4 (de) Polynucleotide, polypeptide und antikörper vom typ b7
EP1341803A4 (de) Neue nukleinsäuren und polypeptide
EP1131350A4 (de) Egf-ähnliche nukleinsäuren und polypeptide und deren anwendungen
EP1282635A4 (de) Neue nukleinsäuren und polypeptide
EP1268762A4 (de) Neue nukleinsäuren und polypeptide
HUP0201660A2 (en) Novel polypeptide and dna thereof
ATE328003T1 (de) Chimäre nukleinsäuren und polypeptide aus lyssavirus
DE69840550D1 (de) Polypeptide und polynukleotide und deren verwendungen
EP1203013A4 (de) Kinasehemmende polypeptide und ihre anwendung
EP1370675A4 (de) Neue nukleinsäuren und polypeptide
AU7005801A (en) Gp354 nucleic acids and polypeptides
ATE270675T1 (de) Pro243 polypeptide und dafür kodierende nukleinsäuren
DE60044849D1 (de) Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020624

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12N 15/11 B

Ipc: 7C 07K 14/00 B

Ipc: 7C 12N 15/63 B

Ipc: 7C 07H 21/04 A

Ipc: 7C 07K 14/435 B

Ipc: 7C 12N 15/70 B

A4 Supplementary search report drawn up and despatched

Effective date: 20050509

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20060111